The activity of 6-selenopurine and related compounds against some experimental mouse tumors.

A series of selenium analogs of physiologically active thiopurines and thiopyrimidines has recent ly been prepared (9). The well established antitumor activity of some of the analogous mercapto compounds, particularly 6-mercaptopurine, which has enjoyed wide clinical use in the treatment of various types of leukemia (3,12), indicated the desirability of comparing the chemical and biologi cal properties of these isosterically related com pounds. The selenium compounds, sterically very similar to the corresponding mercapto compounds, are known to be rather different in terms of elec tron distribution, the carbon-selenium double bond being more highly polarized than the carbon-sulfur double bond (9,10). The antimicrobial activity of 6-selenopurine (which, for Lactobacillus casei, was shown to be a purine antagonist) against a wide range of micro organisms was consistently much higher than that of 6-mercaptopurine.1 Similar differences in anti microbial activity had been observed previously in studies of analogous thioand seleno-carbamyl compounds (11). Selenopurine was found to be 5 times more active than mercaptopurine in inhibit ing the growth of mouse leukemia L5178 cells in tissue culture.2 Selenopurine was also found to be considerably more active than mercaptopurine as an inhibitor of chicken kidney xanthine dehydrogenase.3 These results, coupled with the recent findings of Weisberger and Suhrland (17) that "selenium cystine" produced dramatic decreases

[1]  C. Heidelberger,et al.  Fluorinated Pyrimidines, A New Class of Tumour-Inhibitory Compounds , 1957, Nature.

[2]  H. Mautner The Synthesis and Properties of Some Selenopurines and Selenopyrimidines , 1956 .

[3]  W. Shive,et al.  Synthesis of Some 6-(Substituted)-Aminopurines , 1955 .

[4]  S. Sternberg,et al.  THE TOXIC EFFECTS OF 6‐MERCAPTOPURINE AND RELATED COMPOUNDS , 1954, Annals of the New York Academy of Sciences.

[5]  L. Law,et al.  RESPONSE OF ACUTE LYMPHOCYTIC LEUKEMIAS TO THE PURINE ANTAGONIST 6‐MERCAPTOPURINE , 1954, Annals of the New York Academy of Sciences.

[6]  S. Greenhouse,et al.  STUDIES ON THE TOXICITY AND ANTILEUKEMIC ACTION OF 6‐MERCAPTOPURINE IN MICE , 1954, Annals of the New York Academy of Sciences.

[7]  S. Sternberg,et al.  EFFECTS OF 6‐MERCAPTOPURINE AND ANALOGS ON EXPERIMENTAL TUMORS , 1954, Annals of the New York Academy of Sciences.

[8]  S. Sternberg,et al.  6-Mercaptopurine: effects in mouse sarcoma 180 and in normal animals. , 1953, Cancer research.

[9]  C. P. Rhoads,et al.  Inhibition of Development of Sarcoma 180 by 4-Amino-N10-Methyl Pteroylglutamic Acid.* , 1949, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[10]  H. Mautner,et al.  Antifungal activity of some substituted selenosemicarbazones and related compounds. , 1956, Antibiotics & chemotherapy.

[11]  H. Mautner,et al.  2-Phenylselenosemicarbazide and Related Compounds. Dipole Moment and Spectroscopic Measurements on Analogous Ureides, Thioureides, and Selenoureides1,2 , 1956 .

[12]  A. Weisberger,et al.  Studies on analogues of L-cysteine and L-cystine. III. The effect of selenium cystine on leukemia. , 1956, Blood.

[13]  Joseph Seifter,et al.  Studies on analogues of L-cysteine and L-cystine. I. Some structural requirements for inhibiting the incorporation of radioactive L-cystine by leukemic leukocytes. , 1956, Blood.